Sign up
Log in
12 Health Care Stocks Moving In Friday's Intraday Session
Share
Listen to the news

Gainers

  • Impact BioMedical (AMEX:IBO) stock increased by 73.1% to $0.8 during Friday's regular session. The company's market cap stands at $9.2 million.
  • Regencell Bioscience (NASDAQ:RGC) stock rose 43.62% to $34.9. The market value of their outstanding shares is at $454.1 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock rose 37.05% to $0.52. The company's market cap stands at $1.7 million.
  • Aldeyra Therapeutics (NASDAQ:ALDX) shares rose 32.04% to $1.88. The company's market cap stands at $111.6 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 23.95% to $3.57. The market value of their outstanding shares is at $54.3 million.
  • Kairos Pharma (AMEX:KAPA) shares moved upwards by 22.34% to $1.15. The company's market cap stands at $15.7 million.

Losers

  • NeuroOne Medical Tech (NASDAQ:NMTC) stock declined by 44.3% to $0.48 during Friday's regular session. The market value of their outstanding shares is at $14.7 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares fell 32.16% to $1.35. The market value of their outstanding shares is at $1.9 million.
  • Lifecore Biomedical (NASDAQ:LFCR) stock fell 22.62% to $5.27. The company's market cap stands at $195.1 million. As per the press release, Q3 earnings came out yesterday.
  • ProPhase Labs (NASDAQ:PRPH) stock fell 22.2% to $0.27. The company's market cap stands at $8.1 million. As per the news, the Q4 earnings report came out 4 days ago.
  • NewGenIvf Group (NASDAQ:NIVF) stock declined by 22.11% to $0.44. The market value of their outstanding shares is at $2.3 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) shares decreased by 20.6% to $0.26. The market value of their outstanding shares is at $66.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.